C J Li
Impact in
- Toxicology top 0.5%
- Bioactive Compounds and Antitumor Agents
- Virology top 5%
- HIV Research and Treatment
Papers in
-
- Cancer therapeutics and mechanisms 4
- Ubiquitin and proteasome pathways 1
- Protein Degradation and Inhibitors 1
- Oncology 3
- Cancer-related Molecular Pathways 2
- Polyomavirus and related diseases 1
- Co-authors
- Arthur B. Pardee (3 shared papers)Lidia Averboukh (1 shared paper)A B Pardee (2 shared papers)Clyde S. Crumpacker (2 shared papers)Bruce J. Dezube (2 shared papers)Chao Wang (2 shared papers)David J. Friedman (1 shared paper)Roland Pálffy (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Journal of Biological Chemistry (2 papers)Gene Therapy (1 paper)Journal of Medicinal Chemistry (1 paper)Clinical & Translational Oncology (1 paper)
- Partner nations
- United StatesChinaRussia
In The Last Decade
C J Li
8 papers receiving 593 citations
Peers
Comparison fields: 5 of 71
- Toxicology 188
- Virology 111
- Molecular Medicine 78
- Molecular Biology 347
- Oncology 115
Countries citing papers authored by C J Li
This map shows the geographic impact of C J Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C J Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C J Li more than expected).
Fields of papers citing papers by C J Li
This network shows the impact of papers produced by C J Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C J Li. The network helps show where C J Li may publish in the future.
Co-authors
The 17 scholars most cited alongside C J Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 197 | |
| 2 | 1993 | 197 | |
| 3 | 1995 | 105 | |
| 4 | 2011 | 44 | |
| 5 | 1994 | 32 | |
| 6 | 1997 | 21 | |
| 7 | 2024 | 16 | |
| 8 | 2021 | 8 |
About C J Li
C J Li is a scholar working on Molecular Biology, Oncology, Infectious Diseases, Toxicology and Organic Chemistry, having authored 8 papers that have together received 620 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (4 papers), Bioactive Compounds and Antitumor Agents (2 papers), Cancer-related Molecular Pathways (2 papers), HIV/AIDS drug development and treatment (2 papers), Ubiquitin and proteasome pathways (1 paper), Protein Degradation and Inhibitors (1 paper), Polyomavirus and related diseases (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Toxicology (188 citations), Virology (111 citations), Molecular Medicine (78 citations), Molecular Biology (347 citations) and Oncology (115 citations). C J Li has collaborated with scholars based in United States, China and Russia. Frequent co-authors include Arthur B. Pardee, Lidia Averboukh, A B Pardee, Clyde S. Crumpacker, Bruce J. Dezube, Chao Wang, David J. Friedman, Roland Pálffy, Peter Celec and Michal Behuliak. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry, Gene Therapy, Journal of Medicinal Chemistry and Clinical & Translational Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.